This webinar summarizes the outcome of the Medicare gapfilling process for 114 new molecular pathology (MoPath) codes that were implemented in 2013. The presentation addresses the final 2013 regional rates for these codes and the implications for national payment rates in 2014. We will discuss future changes in the molecular diagnostic reimbursement landscape and potential impact on clinical laboratories.